|
|
Could it be time to invest in a biotech ETF? This was supposed to be the biotech century, where innovation was to lead to efficient, sustainable energy and gene-based drugs were to replace chemically-formulated compounds. Biotech innovation was to lead to efficient and sustainable fuels.
Biotech ETF is an exchange-traded fund that consists of a basket of few Biotechnology firms.
There are currently five popular biotech ETFs, each differing by the number of stocks held and the indices mirrored. These five include:
- SPDR Biotech ETF (XBI): Standard & Poor's Depository Receipts or SPDRs is a US-based exchange-traded fund which is specifically linked to the S&P 500. SPDRs belong to a family of exchange-traded funds managed by State Street Global Advisors, called the SPDR ETFs.
The SPDR S&P Biotech ETF seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index.
- PowerShares Dynamic Biotech & Genome (PBE): The PowerShares Dynamic Biotechnology & Genome Portfolio Fund seeks to replicate the Dynamic Biotechnology & Genome Intellidex Index, which is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors.
- iShares NASDAQ Biotechnology (IBB): The iShares Nasdaq Biotechnology Index Fund seeks to provide investment results generally equivalent to companies primarily engaged in the biotechnology industry, as represented by the NASDAQ Biotechnology Index.
- First Trust AMEX Biotechnology (FBT): The investment objective of the First Trust AMEX Biotechnology Index Fund is to replicate as closely as possible the price and yield of the AMEX Biotechnology Index.
- Biotech HOLDRs (BBH): Biotech HOLDRS are depositary receipts issued by the Biotech HOLDRS Trust, and represent an undivided beneficial ownership in the common stock or American depositary shares of a group of specified companies that are involved in various segments of the biotechnology industry.
|
|
|
| ETF Global Investor |
Newsletter Frequency: Weekly (every Monday morning)
Delivery format:
PDF file via E-mail and Website
Click here to view FREE issue
Subscription:
30 day trial for just $1.00
$49.97 per month thereafter
Satisfaction guaranteed: If you're not 100% satisfied with ETF Global Investor during or after your 30-day trial, simply cancel through our website and your credit card will not be charged.
Not a subscriber yet?
Download latest issue for $14.97
How to use? Click here
Click here to view Track Record
|
|
